Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)

Introduction: Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in patients with severe infections, malignancy or autoimmune diseases. It is also a rare complication of haematopoetic stem cell...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Front Immunol
المؤلفون الرئيسيون: Sandler, Robert David, Tattersall, Rachel Scarlett, Schoemans, Helene, Greco, Raffaella, Badoglio, Manuela, Labopin, Myriam, Alexander, Tobias, Kirgizov, Kirill, Rovira, Montserrat, Saif, Muhammad, Saccardi, Riccardo, Delgado, Julio, Peric, Zinaida, Koenecke, Christian, Penack, Olaf, Basak, Grzegorz, Snowden, John Andrew
التنسيق: Artigo
اللغة:Inglês
منشور في: Frontiers Media S.A. 2020
الموضوعات:
Immunology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137396/
https://ncbi.nlm.nih.gov/pubmed/32296434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00524
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة